{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:54:10Z","timestamp":1787648050157,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12094-017-1685-3","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T16:50:27Z","timestamp":1496422227000},"page":"1478-1488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-0856","authenticated-orcid":false,"given":"C. A.","family":"Castaneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7422-0661","authenticated-orcid":false,"given":"C.","family":"Torres-Cabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0111-3176","authenticated-orcid":false,"given":"M.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Casavilca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De La Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Cotrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Galvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Abugattas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"issue":"2","key":"1685_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cll.2011.03.005","volume":"31","author":"MP Piliang","year":"2011","unstructured":"Piliang MP. Acral lentiginous melanoma. Clin Lab Med. 2011;31(2):281\u20138.","journal-title":"Clin Lab Med"},{"issue":"4","key":"1685_CR2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","volume":"145","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986\u20132005. Arch Dermatol. 2009;145(4):427\u201334.","journal-title":"Arch Dermatol"},{"key":"1685_CR3","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jaad.2010.12.028","volume":"65","author":"XC Wu","year":"2011","unstructured":"Wu XC, Eide MJ, King J, Saraiya M, Huang Y, Wiggins C, et al. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999\u20132006. J Am Acad Dermatol. 2011;65:S26\u201337.","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"1685_CR4","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1245\/s10434-016-5394-x","volume":"23","author":"LS Lino-Silva","year":"2016","unstructured":"Lino-Silva LS, Dominguez-Rodriguez JA, Aguilar-Romero JM, Martinez-Said H, Salcedo-Hernandez RA, Garcia-Perez L, et al. Melanoma in Mexico: clinicopathologic features in a population with predominance of acral lentiginous subtype. Ann Surg Oncol. 2016;23(13):4189\u201394.","journal-title":"Ann Surg Oncol"},{"key":"1685_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13104-015-0972-8","volume":"8","author":"L Vazquez Vde","year":"2015","unstructured":"Vazquez Vde L, Silva TB, Vieira Mde A, de Oliveira AT, Lisboa MV, de Andrade DA, et al. Melanoma characteristics in Brazil: demographics, treatment, and survival analysis. BMC Res Notes. 2015;8:4.","journal-title":"BMC Res Notes"},{"issue":"3","key":"1685_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0123-9015(13)70013-1","volume":"17","author":"F Pozzobon","year":"2013","unstructured":"Pozzobon F, Fierro E, Acosta \u00c1, Carre\u00f1oc A. Caracter\u00edsticas del melanoma cut\u00e1neo primario en el Instituto Nacional de Cancerolog\u00eda 2006\u20132010. Revista Colombiana de Cancerolog\u00eda. 2013;17(3):111\u20138.","journal-title":"Revista Colombiana de Cancerolog\u00eda"},{"issue":"3","key":"1685_CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2230.2005.02038.x","volume":"31","author":"V Zemelman","year":"2006","unstructured":"Zemelman V, Roa J, Tagle SR, Valenzuela CY. Malignant melanoma in Chile: an unusual distribution of primary sites in men from low socioeconomic strata. Clin Exp Dermatol. 2006;31(3):335\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"1685_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2133.2006.07368.x","volume":"155","author":"A Phan","year":"2006","unstructured":"Phan A, Touzet S, Dalle S, Ronger-Savle S, Balme B, Thomas L. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol. 2006;155(3):561\u20139.","journal-title":"Br J Dermatol"},{"key":"1685_CR9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00003086-200009000-00031","volume":"378","author":"JA O\u2019Leary","year":"2000","unstructured":"O\u2019Leary JA, Berend KR, Johnson JL, Levin LS, Seigler HF. Subungual melanoma. A review of 93 cases with identification of prognostic variables. Clin Orthop Relat Res. 2000;378:206\u201312.","journal-title":"Clin Orthop Relat Res"},{"key":"1685_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1008872014889","volume":"10","author":"A Green","year":"1999","unstructured":"Green A, McCredie M, MacKie R, Giles G, Young P, Morton C, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control. 1999;10:21\u20135.","journal-title":"Cancer Causes Control"},{"issue":"6","key":"1685_CR11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjsurg.2012.05.013","volume":"204","author":"ME Egger","year":"2012","unstructured":"Egger ME, McMasters KM, Callender GG, Quillo AR, Martin RC 2nd, Stromberg AJ, et al. Unique prognostic factors in acral lentiginous melanoma. Am J Surg. 2012;204(6):874\u20139 (discussion 9\u201380).","journal-title":"Am J Surg"},{"issue":"5 Suppl 1","key":"1685_CR12","first-page":"S78","volume":"65","author":"LA Pollack","year":"2011","unstructured":"Pollack LA, Li J, Berkowitz Z, Weir HK, Wu XC, Ajani UA, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5 Suppl 1):S78\u201386.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1685_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2133.2000.03651.x","volume":"143","author":"C Kuchelmeister","year":"2000","unstructured":"Kuchelmeister C, Schaumburg-Lever G, Garbe C. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol. 2000;143(2):275\u201380.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1685_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jso.2930450207","volume":"45","author":"CL Slingluff Jr","year":"1990","unstructured":"Slingluff CL Jr, Vollmer R, Seigler HF. Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol. 1990;45(2):91\u20138.","journal-title":"J Surg Oncol"},{"issue":"12","key":"1685_CR15","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1097\/PAS.0b013e318073c600","volume":"31","author":"KB Tan","year":"2007","unstructured":"Tan KB, Moncrieff M, Thompson JF, McCarthy SW, Shaw HM, Quinn MJ, et al. Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting. Am J Surg Pathol. 2007;31(12):1902\u201312.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"1685_CR16","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1245\/s10434-013-3089-0","volume":"20","author":"DM Bello","year":"2013","unstructured":"Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, et al. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013;20(11):3618\u201325.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1685_CR17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","volume":"44","author":"M Krauthammer","year":"2012","unstructured":"Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012;44(9):1006\u201314.","journal-title":"Nat Genet"},{"issue":"20","key":"1685_CR18","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135\u201347.","journal-title":"N Engl J Med"},{"issue":"4","key":"1685_CR19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1755-148X.2012.01016.x","volume":"25","author":"SJ Furney","year":"2012","unstructured":"Furney SJ, Turajlic S, Fenwick K, Lambros MB, MacKay A, Ricken G, et al. Genomic characterisation of acral melanoma cell lines. Pigment Cell Melanoma Res. 2012;25(4):488\u201392.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"26","key":"1685_CR20","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24(26):4340\u20136.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1685_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1101\/gr.125591.111","volume":"22","author":"S Turajlic","year":"2012","unstructured":"Turajlic S, Furney SJ, Lambros MB, Mitsopoulos C, Kozarewa I, Geyer FC, et al. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res. 2012;22(2):196\u2013207.","journal-title":"Genome Res"},{"issue":"5","key":"1685_CR22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2559.1983.tb02279.x","volume":"7","author":"VJ McGovern","year":"1983","unstructured":"McGovern VJ, Shaw HM, Milton GW. Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology. 1983;7(5):673\u201380.","journal-title":"Histopathology"},{"issue":"7","key":"1685_CR23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","volume":"77","author":"CG Clemente","year":"1996","unstructured":"Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996;77(7):1303\u201310.","journal-title":"Cancer"},{"issue":"4","key":"1685_CR24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1309\/WBF7-N8KH-71KT-RVQ9","volume":"118","author":"RJ Tuthill","year":"2002","unstructured":"Tuthill RJ, Unger JM, Liu PY, Flaherty LE, Sondak VK, Southwest Oncology G. Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model. Am J Clin Pathol. 2002;118(4):504\u201311.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"1685_CR25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ijc.23543","volume":"123","author":"IS Houdt van","year":"2008","unstructured":"van Houdt IS, Sluijter BJ, Moesbergen LM, Vos WM, de Gruijl TD, Molenkamp BG, et al. Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. Int J Cancer. 2008;123(3):609\u201315.","journal-title":"Int J Cancer"},{"issue":"1","key":"1685_CR26","first-page":"43","volume":"74","author":"MC Mihm Jr","year":"1996","unstructured":"Mihm MC Jr, Clemente CG, Cascinelli N. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest. 1996;74(1):43\u20137.","journal-title":"Lab Invest"},{"issue":"1","key":"1685_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00262-007-0353-9","volume":"57","author":"F Hillen","year":"2008","unstructured":"Hillen F, Baeten CI, van de Winkel A, Creytens D, van der Schaft DW, Winnepenninckx V, et al. Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma. Cancer Immunol Immunother. 2008;57(1):97\u2013106.","journal-title":"Cancer Immunol Immunother"},{"issue":"14","key":"1685_CR28","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ejca.2009.05.034","volume":"45","author":"M Mandala","year":"2009","unstructured":"Mandala M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, et al. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I\u2013II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Eur J Cancer. 2009;45(14):2537\u201345.","journal-title":"Eur J Cancer"},{"issue":"48","key":"1685_CR29","doi-asserted-by":"crossref","first-page":"20429","DOI":"10.1073\/pnas.0905139106","volume":"106","author":"D Bogunovic","year":"2009","unstructured":"Bogunovic D, O\u2019Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, et al. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci USA. 2009;106(48):20429\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1685_CR30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/000313481107700219","volume":"77","author":"AL Burton","year":"2011","unstructured":"Burton AL, Roach BA, Mays MP, Chen AF, Ginter BA, Vierling AM, et al. Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg. 2011;77(2):188\u201392.","journal-title":"Am Surg"},{"issue":"21","key":"1685_CR31","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","volume":"30","author":"F Azimi","year":"2012","unstructured":"Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21):2678\u201383.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1685_CR32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2006.08.9755","volume":"25","author":"RC Taylor","year":"2007","unstructured":"Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol. 2007;25(7):869\u201375.","journal-title":"J Clin Oncol"},{"issue":"31","key":"1685_CR33","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1200\/JCO.2005.02.0735","volume":"23","author":"PA Gimotty","year":"2005","unstructured":"Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, et al. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. J Clin Oncol. 2005;23(31):8048\u201356.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1685_CR34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<427::AID-CNCR8>3.0.CO;2-G","volume":"78","author":"RL Barnhill","year":"1996","unstructured":"Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer. 1996;78(3):427\u201332.","journal-title":"Cancer"},{"issue":"4","key":"1685_CR35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1245\/ASO.2005.05.016","volume":"12","author":"SL Wong","year":"2005","unstructured":"Wong SL, Kattan MW, McMasters KM, Coit DG. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol. 2005;12(4):282\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"1685_CR36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ejso.2011.05.007","volume":"37","author":"S Pasquali","year":"2011","unstructured":"Pasquali S, Mocellin S, Campana L, Vecchiato A, Bonandini E, Montesco M, et al. Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma. Eur J Surg Oncol. 2011;37(8):675\u201380.","journal-title":"Eur J Surg Oncol"},{"issue":"36","key":"1685_CR37","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199\u2013206.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1685_CR38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/cncr.21654","volume":"106","author":"MG Cockburn","year":"2006","unstructured":"Cockburn MG, Zadnick J, Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer. 2006;106(5):1162\u20138.","journal-title":"Cancer"},{"key":"1685_CR39","doi-asserted-by":"crossref","first-page":"31432","DOI":"10.1038\/srep31432","volume":"6","author":"J Lv","year":"2016","unstructured":"Lv J, Dai B, Kong Y, Shen X, Kong J. Acral melanoma in Chinese: a clinicopathological and prognostic study of 142 cases. Sci Rep. 2016;6:31432.","journal-title":"Sci Rep."},{"issue":"2","key":"1685_CR40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10434-000-0160-4","volume":"7","author":"JE Gershenwald","year":"2000","unstructured":"Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (\u22654\u00a0mm) primary melanoma. Ann Surg Oncol. 2000;7(2):160\u20135.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"1685_CR41","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307\u201317.","journal-title":"N Engl J Med"},{"issue":"6","key":"1685_CR42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1245\/ASO.2005.03.074","volume":"12","author":"VS Yee","year":"2005","unstructured":"Yee VS, Thompson JF, McKinnon JG, Scolyer RA, Li LX, McCarthy WH, et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol. 2005;12(6):429\u201339.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1685_CR43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jso.20083","volume":"86","author":"RA Scolyer","year":"2004","unstructured":"Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW. Pathology of melanocytic lesions: new, controversial, and clinically important issues. J Surg Oncol. 2004;86(4):200\u201311.","journal-title":"J Surg Oncol"},{"issue":"10","key":"1685_CR44","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1524-4725.2009.01265.x","volume":"35","author":"J Rex","year":"2009","unstructured":"Rex J, Paradelo C, Mangas C, Hilari JM, Fernandez-Figueras MT, Ferrandiz C. Management of primary cutaneous melanoma of the hands and feet: a clinicoprognostic study. Dermatol Surg. 2009;35(10):1505\u201313.","journal-title":"Dermatol Surg"},{"issue":"4","key":"1685_CR45","first-page":"366","volume":"29","author":"M Moehrle","year":"2003","unstructured":"Moehrle M, Metzger S, Schippert W, Garbe C, Rassner G, Breuninger H. \u201cFunctional\u201d surgery in subungual melanoma. Dermatol Surg. 2003;29(4):366\u201374.","journal-title":"Dermatol Surg"},{"issue":"6","key":"1685_CR46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2106\/00004623-199406000-00013","volume":"76","author":"BC Barnes","year":"1994","unstructured":"Barnes BC, Seigler HF, Saxby TS, Kocher MS, Harrelson JM. Melanoma of the foot. J Bone Joint Surg Am. 1994;76(6):892\u20138.","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"1685_CR47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2133.2011.10772.x","volume":"166","author":"F Durbec","year":"2012","unstructured":"Durbec F, Martin L, Derancourt C, Grange F. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol. 2012;166(4):727\u201339.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1685_CR48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000658-199402000-00012","volume":"219","author":"KM Heaton","year":"1994","unstructured":"Heaton KM, Naggar A, Ensign LG, Ross MI, Balch CM. Surgical management and prognostic factors in patients with subungual melanoma. Ann Surg. 1994;219(2):197\u2013204.","journal-title":"Ann Surg"},{"issue":"11","key":"1685_CR49","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/modpathol.2009.116","volume":"22","author":"CA Torres-Cabala","year":"2009","unstructured":"Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, et al. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous\/mucosal type. Mod Pathol. 2009;22(11):1446\u201356.","journal-title":"Mod Pathol"},{"issue":"129","key":"1685_CR50","first-page":"62","volume":"61","author":"G Paolino","year":"2016","unstructured":"Paolino G, Bekkenk M, Didona D, Eibenschutz L, Richetta A, Cantisani C, et al. Is the prognosis and course of acral melanoma related to site-specific clinicopathological features? Age. 2016;61(129):62.","journal-title":"Age"},{"issue":"1","key":"1685_CR51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/CMR.0000000000000311","volume":"27","author":"G Paolino","year":"2017","unstructured":"Paolino G, Panetta C, Cota C, Didona D, Moliterni E, Di Mattia C, et al. Vitamin D receptor immunohistochemistry variability in sun-exposed and non-sun-exposed melanomas. Melanoma Res. 2017;27(1):17\u201323.","journal-title":"Melanoma Res"},{"key":"1685_CR52","doi-asserted-by":"crossref","unstructured":"Johnson DB, Peng C, Abramson RG, Wolchok JD, Sosman JA, Carvajal RD, Ariyan CE. Ipilimumab in acral melanoma: A retrospective review. ASCO Annual Meeting Abstracts. J Clin Oncol 2014;32(15_suppl) (May 20 Supplement), Abstract 9056.","DOI":"10.1200\/jco.2014.32.15_suppl.9056"},{"issue":"13","key":"1685_CR53","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMc1509660","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Hodi FS, Wolchok JD. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373(13):1270\u20131.","journal-title":"N Engl J Med"},{"issue":"26","key":"1685_CR54","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 2015;372(26):2521\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"1685_CR55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9610(81)90286-5","volume":"142","author":"CL Day Jr","year":"1981","unstructured":"Day CL Jr, Sober AJ, Kopf AW, Lew RA, Mihm MC Jr, Golomb FM, et al. A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. Am J Surg. 1981;142(2):247\u201351.","journal-title":"Am J Surg"},{"issue":"24","key":"1685_CR56","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","volume":"81","author":"WH Clark Jr","year":"1989","unstructured":"Clark WH Jr, Elder DE, Dt Guerry, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81(24):1893\u2013904.","journal-title":"J Natl Cancer Inst"},{"issue":"34","key":"1685_CR57","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2016.67.2477","volume":"34","author":"AI Daud","year":"2016","unstructured":"Daud AI, Wolchok JD, Robert C, Hwu WJ, Weber JS, Ribas A, et al. Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma. J Clin Oncol. 2016;34(34):4102\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1685_CR58","doi-asserted-by":"crossref","first-page":"e0130142","DOI":"10.1371\/journal.pone.0130142","volume":"10","author":"L Carbognin","year":"2015","unstructured":"Carbognin L, Pilotto S, Milella M, Vaccaro V, Brunelli M, Calio A, et al. Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): sensitivity analysis of trials in melanoma, lung and genitourinary cancers. PLoS ONE. 2015;10(6):e0130142.","journal-title":"PLoS ONE"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-017-1685-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-017-1685-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-017-1685-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T09:52:03Z","timestamp":1602237123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-017-1685-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1685"],"URL":"https:\/\/doi.org\/10.1007\/s12094-017-1685-3","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,2]]}}}